Board
Screen
Heat
Cal
Watch
News
Blog
TV
Home
/
ANAB
Home
/
ANAB

NASDAQ
$46.92
$46.92

Overview

Price performance
Low
$45.86
High
$49.00
Market open. Last updated: Nov 4, 2026, 8:08 PM UTC
$
46.92
-0.81 (-1.70%)
Average, 50 days
$51.33
$50.57
Open
$49.00
Previous close
$47.73
52-week high
$72.36
May 5, 2026 (7 months ago)
52-week low
$20.18
Nov 10, 2025 (1 year ago)
132.51%

Valuation & Estimates

Earnings

Financials

Insider Trading

Peer Analysis

Insights & Activity

Market Cap
1.40B
Volume
268 914
Total Return (3M)
-14.79%
Total Return (1Y)
102.82%
5.70
Sector
Healthcare
Links
Tags
Healthcare
Biotechnology
NASDAQ
US
Website
anaptysbio.com
About
AnaptysBio, Inc., a clinical-stage biotechnology company, focuses in delivering immunology therapeutics for autoimmune and inflammatory diseases in the United States. The company’s products include Rosnilimab, a selective pathogenic T cell deplete which completed a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis; ANB033, a CD122 antagonist, which is in a Phase 1b trial for celiac disease and eosinophilic esophagitis; ANB101, a BDCA2 modulator antibody which is in Phase 1a trial that specifically targets plasmacytoid dendritic cells and inhibits interferon secretion and modulates antigen presentation; dostarlimab, a PD-1 antagonist for various solid tumor indications; and Imsidolimab, an antibody that inhibits the interleukin-36 receptor, which is in the Phase 3 development for the treatment of generalized pustular psoriasis. It focuses on developing various antibody programs that are advanced to preclinical and clinical milestones under its collaborations. It has collaborations agreement with GSK and Vanda. The company was formerly known as Anaptys Biosciences, Inc. and changed its name to AnaptysBio, Inc. in July 2006. AnaptysBio, Inc. was incorporated in 2005 and is based in San Diego, California.

Frequently asked questions

ANAB · AnaptysBio, Inc.

01What is AnaptysBio, Inc. stock price today?

The current price of ANAB is $46.92 — it has decreased by 1.70% since the previous close. Data as of Nov 4, 2026.

02Is AnaptysBio, Inc. stock price growing?

ANAB is down 3.50% over the past week, down 3.21% over the past month and up 102.82% over the past year. The price is below its 200-day moving average of $50.57.

03What is AnaptysBio, Inc. market cap?

AnaptysBio, Inc. has a market capitalization of $1.4B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.

04What were AnaptysBio, Inc. earnings last quarter?

In its most recent quarterly report, AnaptysBio, Inc. posted earnings of $5.11 per share, in line with the estimate of $5.11. Upcoming reports are listed in the earnings calendar.

05What is AnaptysBio, Inc. revenue for the last quarter?

AnaptysBio, Inc. reported revenue of $27.49M in its most recent quarter, which has increased by 23.47% compared with the same quarter a year earlier. Analysts had expected $27.49M.

06How volatile is ANAB stock?

In the latest trading session ANAB moved between $45.86 and $49.00, a range of 6.69% of its current price.

07Should I invest in AnaptysBio, Inc. stock?

Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of AnaptysBio, Inc. shows a sell rating today. Technical ratings are indicators, not investment advice.

08What are ANAB stock 52-week high and low?

Over the past 52 weeks ANAB has traded between $20.18 and $72.36. The current price is 35.16% below its 52-week high.

Figures as of Nov 4, 2026. This information is provided for general purposes only and is not investment advice.